全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Salvage of Failed Local and Regional Flaps with Porcine Urinary Bladder Extracellular Matrix Aided Tissue Regeneration

DOI: 10.1155/2013/917183

Full-Text   Cite this paper   Add to My Lib

Abstract:

Local and regional flap failure can be a major complication in head and neck surgery, which continue to be prevalent for a number of reasons including poor flap design, improper surgical technique, and poor tissue vascularity. Dealing with these failures can be quite difficult. Surgical debridement, flap revisions, and complex wound regimens are necessitated to reestablish appropriate tissue coverage. Traditional use of wet to dry dressing to enable proper wound granulation and possible closure with additional flaps or skin grafts is a laborious process. Such treatments place great time burdens on the patient, physicians, and nurses. Because the face and neck possess a complex three-dimensional topography, wound dressings are inherently complex to design and change. Many patients also require postoperative treatments such as radiation and chemotherapy to treat aggressive malignancies, and delay in wound healing leads to a delay in adjuvant treatment. Recently, advances in regenerative medicine, specifically xenogeneic extracellular matrix compounds, have been shown to promote tissue growth while limiting scar tissue formation (Badylak 2004). To our knowledge, this paper is the first case series using the porcine extracellular matrix bioscaffold (MatriStem ACell, Columbia, MD, USA) to salvage flaps with extensive wound breakdown on the face and neck. 1. Introduction Local and regional flap survival depends on proper design, meticulous surgical technique, and factors intrinsic to the patient. Modern head and neck surgeons see many patients who have extensive medical co-morbidities such as diabetes, collagen vascular disorders, and peripheral vascular disease that make the survival of local random flaps and even pedicled flaps more tenuous [1]. In addition, smoking, malnutrition, and fluid overload during surgery may increase the likelihood of flap failure [2]. Flap failure increases the length of surgical stay, places additional economic burden on the health care system, and can delay adjuvant therapy in cases of malignancy. Additional medical costs related to flap salvage are mostly found in the vascular surgery and chronic wound literature and estimated conservatively at $30,000 per case [3]. To understand flap failures, one must understand wound healing. Initial injury to skin results in disruption of blood vessels and extravasation of blood cell contents. Aggregation of platelets, fibrinogen, fibrin, and fibronectin forms a blood clot which reestablishes homeostasis. This clot provides the initial matrix for cell attachment and migration. Platelets

References

[1]  B. C. Cooley, D. P. Hanel, R. B. Anderson, M. D. Foster, and J. S. Gould, “The influence of diabetes on free flap transfer: I. Flap survival and microvascular healing,” Annals of Plastic Surgery, vol. 29, no. 1, pp. 58–64, 1992.
[2]  T. D. Rees, D. M. Liverett, and C. L. Guy, “The effect of cigarette smoking on skin-flap survival in the face lift patient,” Plastic and Reconstructive Surgery, vol. 73, no. 6, pp. 911–915, 1984.
[3]  P. E. Cianci, G. Petrone, S. Drager, H. Lueders, H. Lee, and R. Shapiro, “Salvage of the problem wound and potential amputation with wound care and adjunctive hyperbaric oxygen therapy: an economic analysis,” Journal of Hyperbaric Medicine, vol. 3, no. 3, pp. 127–141, 1988.
[4]  S. A. Eming, T. Krieg, and J. M. Davidson, “Inflammation in wound repair: molecular and cellular mechanisms,” Journal of Investigative Dermatology, vol. 127, no. 3, pp. 514–525, 2007.
[5]  S. F. Badylak, “Xenogeneic extracellular matrix as a scaffold for tissue reconstruction,” Transplant Immunology, vol. 12, no. 3-4, pp. 367–377, 2004.
[6]  B. Brown, K. Lindberg, J. Reing, D. B. Stolz, and S. F. Badylak, “The basement membrane component of biologic scaffolds derived from extracellular matrix,” Tissue Engineering, vol. 12, no. 3, pp. 519–526, 2006.
[7]  M. Regnier, J. Schweizer, and S. Michel, “Expression of high molecular weight (67K) keratin in human keratinocytes cultured on dead de-epidermized dermis,” Experimental Cell Research, vol. 165, no. 1, pp. 63–72, 1986.
[8]  E. P. Brennan, J. Reing, D. Chew, J. M. Myers-Irvin, E. J. Young, and S. F. Badylak, “Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix,” Tissue Engineering, vol. 12, no. 10, pp. 2949–2955, 2006.
[9]  S. F. Badylak, “The extracellular matrix as a scaffold for tissue reconstruction,” Seminars in Cell and Developmental Biology, vol. 13, no. 5, pp. 377–383, 2002.
[10]  T. Zaleski, “‘Active’ products drive wound-care market,” Genetic Engineering and Biotechnology News, vol. 28, no. 9, 2008.
[11]  J. W. Olin, K. M. Beusterien, M. B. Childs, C. Seavey, L. McHugh, and R. I. Griffiths, “Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study,” Vascular Medicine, vol. 4, no. 1, pp. 1–7, 1999.
[12]  G. F. Funk, L. H. Karnell, S. Whitehead, A. Paulino, J. Ricks, and R. B. Smith, “Free tissue transfer versus pedicled flap cost in head and neck cancer,” Otolaryngology, vol. 127, no. 3, pp. 205–212, 2002.
[13]  S. S. Kroll, G. R. D. Evans, D. Goldberg et al., “A comparison of resource costs for head and neck reconstruction with free and pectoralis major flaps,” Plastic and Reconstructive Surgery, vol. 99, no. 5, pp. 1282–1286, 1997.
[14]  K. Bozikov and Z. M. Arnez, “Factors predicting free flap complications in head and neck reconstruction,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 59, no. 7, pp. 737–742, 2006.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133